RUNX3 has an oncogenic role in head and neck cancer

Takaaki Tsunematsu1, Yasusei Kudo, Shinji Iizuka

  • 1Division of Frontier Medical Science, Department of Oral and Maxillofacial Pathobiology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Plos One
|June 13, 2009
PubMed
Abstract

Insights

Runt-related transcription factor 3 (RUNX3) surprisingly acts as an oncogene in head and neck squamous cell carcinoma (HNSCC), promoting cancer growth and resistance to apoptosis. RUNX3 may serve as a marker for HNSCC malignancy and drug response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Runt-related transcription factor 3 (RUNX3) is typically a tumor suppressor.
  • RUNX3 is involved in the transforming growth factor-beta (TGF-β) tumor suppression pathway.
  • Preliminary data indicated higher RUNX3 expression in head and neck squamous cell carcinoma (HNSCC) than normal tissues.

Purpose of the Study:

  • To investigate the role of RUNX3 in HNSCC.
  • To determine if RUNX3 has an oncogenic function in HNSCC.

Main Methods:

  • Analysis of RUNX3 expression in HNSCC tissues.
  • Experimental manipulation of RUNX3 levels (overexpression and knockdown) in HNSCC cells.
  • Assessment of cell growth, apoptosis, and tumorsphere formation.
  • Correlation analysis with methylation status.

Main Results:

  • RUNX3 was frequently expressed in HNSCC and correlated with malignant behavior.
  • RUNX3 overexpression promoted HNSCC cell growth and inhibited apoptosis.
  • RUNX3 knockdown reversed these effects.
  • RUNX3 overexpression enhanced tumorsphere formation.
  • RUNX3 expression correlated with promoter methylation status; low RUNX3 in normal cells was linked to promoter methylation.

Conclusions:

  • RUNX3 exhibits an oncogenic role in HNSCC.
  • Demethylation may contribute to RUNX3 upregulation in HNSCC.
  • RUNX3 expression can predict HNSCC malignancy and response to chemotherapy.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...